Ha-Yeon Kim

1PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 31, 2025
A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults.

Ha-Yeon Kim, Jaeso Cho, Min Kyu Park

Pageof 1

Frequent Collaborators

1 joint publications

Jaeso Cho

1 joint publications

Min Kyu Park

1 joint publications

Dal-Hee Min

1 joint publications

Jun Gi Hwang